Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case-control studies of screening procedures.

G Knox1

  • 1Department of Social Medicine, University of Birmingham, Edgbaston.

Public Health
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Report of Xanthomonas axonopodis Causing Bacterial Leaf Spot on Crape Myrtle.

Plant disease·2019
Same author

First Report of Rose rosette virus Associated with Rose Rosette Disease Infecting Knockout Roses in Florida.

Plant disease·2019
Same author

Hemangioma of the intratemporal vestibular nerve.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·1999
Same author

Atypical presentation of Waardenburg's syndrome type II.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·1999
Same author

Finding of relation between epidural anaesthesia and long-term backache remains valid.

BMJ (Clinical research ed.)·1997
Same author

Secular pattern of congenital oesophageal atresia. 1959.

Journal of epidemiology and community health·1997
Same journal

Machine learning-based insomnia symptom risk classification model for residents of Hebei province.

Public health·2026
Same journal

Rethinking cancer screening in Italy: equity, performance and innovation.

Public health·2026
Same journal

Socioeconomic inequalities in bladder cancer mortality in Canada: Temporal trends over three decades, 1990-2019.

Public health·2026
Same journal

Insights from a social impact bond for the management of long-term conditions in the United Kingdom: A grounded theory analysis.

Public health·2026
Same journal

Factors influencing health-promoting lifestyle among medical personnel: A mixed-methods systematic review.

Public health·2026
Same journal

Impacts of hepatitis B and C prevention programmes on long-term outcomes of advanced liver disease and hepatocellular carcinoma: A systematic review.

Public health·2026
See all related articles

Screening test protective value claims are flawed. Case-control studies incorrectly measure efficacy because negative tests offer no protection, and results depend on unmeasured factors, not just test performance.

Area of Science:

  • Epidemiology
  • Biostatistics
  • Medical Screening

Background:

  • Case-control studies are frequently used to evaluate medical screening procedures.
  • These studies compare the screening histories of individuals with a disease (cases) to those without (controls).
  • The goal is to estimate the protective value of a screening test.

Purpose of the Study:

  • To re-examine the inductive basis of case-control studies evaluating screening procedures.
  • To identify flaws in the methodology used to calculate the protective value of screening tests.
  • To demonstrate why current methods may overestimate or misinterpret test efficacy.

Main Methods:

  • Analysis of the inductive reasoning in existing case-control screening studies.
  • Identification of critical unmeasured parameters influencing screening frequency ratios.

Related Experiment Videos

  • Examination of the logical fallacy in equating negative screening results with protection.

    • Main Results:

    • The ratio of retrospective screening frequencies is critically dependent on unmeasured parameters, not solely procedural efficacy.
    • Negative screening results are common in both case and control groups and do not confer protection.
    • Claims of measured protective value in such studies are potentially or actually flawed.

    Conclusions:

    • Case-control studies, as currently implemented, cannot accurately measure the protective value of screening tests.
    • The concept of 'protective value' derived from drug/vaccine trials is not directly applicable to screening tests in this manner.
    • Methodological reassessment is needed for evaluating the true impact of medical screening procedures.